Millions of eye drops sold across U.S. recalled because they may not be sterile
upi.com • • business
Key Points:
- K.C. Pharmaceuticals has recalled approximately 3.1 million bottles of eight different eye drop products sold across the U.S. due to concerns over sterility.
- The recall, classified as Class II by the FDA, indicates a remote probability of serious health issues and was voluntarily issued on March 3.
- These eye drops were sold at major retailers including CVS, Walgreens, Kroger, and Publix, among others.
- The FDA has not received any reports of injuries linked to the recalled products, and consumers may continue using the drops unless advised otherwise.
- Detailed information about the recalled products, including lot numbers and retailers, is available on the FDA's website.
